IP Library Granted Patent US 9,476,873
Granted Patent B2
US 9,476,873 · App. 14/772,098 · Granted Oct 25, 2016

Vitamin D assays

Inventors: John F. Zielinski (Whitmore Lake, MI); Rory J. Olson (Rochester, MN); Michael C. Mullenix (Saline, MI)
Assignee: Enzo Life Sciences, Inc.
G01N33/5308G01N33/82
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,476,873
App. No.
14/772,098
Granted
Oct 25, 2016
Kind
B2
Abstract

The disclosure relates to methods for measuring levels of 25(OH)vitamin D (250HD) in a mammalian fluid sample. The disclosure further relates to kits for measuring levels of 25(OH)vitamin D (250HD) in a mammalian fluid, the procedure comprising the step of release of the vitamin D from the serum binding protein (DBP), capturing of the released analyte by a specific antibody and competitive assay of the captured vitamin D against a conjugate between the vitamin D and a tracer. The observed signal is inversely proportional to vitamin D concentration.

Claims (13)

1. A method of measuring 25(OH) vitamin D (25OHD) in a mammalian fluid sample comprising:

(a) contacting the sample comprising 25OHD with a dissociation buffer comprising a release reagent consisting of a mixture of 1-butyl-4-methylpyridinium chloride, 1-ethyl-3-methylpyridinium ethyl sulfate, methyl β-cyclodextrin and sodium salicylate in a well of a microtiter plate;

(b) contacting the mixture of step (a) with (i) add-in 25OHD conjugated to an enzyme and an antibody that specifically binds to 25OHD;

(c) washing the well to remove add-in 25OHD that is not specifically bound;

(d) adding a substrate of said enzyme conjugated to add-in 25OHD;

(e) quantitatively measuring a signal produced by the reaction of substrate and enzyme in the well; and

(f) comparing the measured signal to a standard curve created with known quantities of 25OHD3, 25OHD2, or a mixture thereof, to determine the amount of 25OHD in the sample.

2. The method of claim 1 , wherein the antibody is selected from a monoclonal antibody, a polyclonal antibody, or an antigen binding fragment of antibody.

3. The method of claim 1 , wherein the antibody is in solution.

4. The method of claim 1 , wherein the antibody is bound to the surface of the well.

5. The method of claim 4 , wherein the antibody is bound to said surface directly.

6. The method of claim 4 , wherein the antibody is bound to said surface indirectly.

7. The method of claim 6 , wherein the antibody is bound to said surface by a secondary antibody that specifically binds to said antibody.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2015
From: ZIELINSKI, JOHN F.; OLSON, RORY J.; MULLENIX, MICHAEL C.
To: ENZO LIFE SCIENCES, INC.
Reel/Frame 036772/0572 →
Continuity (2)
Continuation 13826747 · Mar 14, 2013
Related Publication 20160018390A1 · Jan 21, 2016